Article
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
17 Aug 2018
Abstract excerpt
INTRODUCTION: Aberrant levels of kallikrein-related peptidases (KLK1-15) have been linked to cancer cell proliferation, invasion and metastasis. In ovarian cancer, the KLK proteolytic network has a crucial role in the tissue and tumor microenvironment. Publically available ovarian cancer genome and expression data from multiple patient cohorts show an upregulation of most KLKs. Areas covered: Here, we review the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
